Affordable Access

International study of ketanserin in Raynaud's phenomenon.

Authors
  • Coffman, J D
  • Clement, D L
  • Creager, M A
  • Dormandy, J A
  • Janssens, M M
  • McKendry, R J
  • Murray, G D
  • Nielsen, S L
Type
Published Article
Journal
The American Journal of Medicine
Publisher
Elsevier
Publication Date
Sep 01, 1989
Volume
87
Issue
3
Pages
264–268
Identifiers
PMID: 2672807
Source
Medline
License
Unknown

Abstract

Ketanserin significantly improves the subjective symptoms of patients with primary or secondary Raynaud's phenomenon and is an appropriate agent to use in this disease when conservative measures fail.

Report this publication

Statistics

Seen <100 times